IGF1 and acromegaly: In one study [92], wide variability in IGF-I levels was seen upon weekly assessments in patients treated with long-acting octreotide or lanreotide, but not in acromegaly patients in continued postoperative remission not treated with SRL or in healthy controls (LQ).